He Lijie, Jiang Zhongmin, Wang Jing, Han Zhe
Department of Clinical Laboratory, Tianjin Fifth Central Hospital, 41 Zhejiang Road, Tianjin, 300450, People's Republic of China.
Department of Pathology, Tianjin Fifth Central Hospital, Tianjin, 300450, People's Republic of China.
Sci Rep. 2025 May 6;15(1):15742. doi: 10.1038/s41598-025-00224-x.
The purpose of this study was to investigate how miR-200b-3p inhibits the proliferation and metastasis of endometrial cancer cells by inducing the expression of FOSL2 in the AP1 transcription family. Endometrial cancer cell line HEC-1-A was divided into 16 groups: NC-mimic (transfected with negative control NC mimic), miR-200b-3p mimic (transfected with miR-200b-3p mimic), NC-suppress (transfected with negative control NC inhibit), miR-200b-3p inhibit group (transfected with miR-200b-3p inhibit), si-NC (transfected with negative control si-NC), si-FOSL2 (transfected with Si-FOSL2), oe-NC (transfected with negative control oe-NC), oe-FOSL2 group (oe-FOSL2), miR-200b-3p mimic + oe-NC group (co-transfected with miR-200b-3p mimic and oe-NC), miR-200b-3p mimic + oe-FOSL2 group (co-transfected with miR-200b-3p mimic and oe-FOSL2), miR-200b-3p inhibit + si-NC group (co-transfected with miR-200b-3p inhibit and si-NC), miR-200b-3p inhibit + si-FOSL2 group (co-transfected with miR-200b-3p inhibit and si-FOSL2), miR-200b-3p mimic + si-NC group (co-transfected with miR-200b-3p mimic and si-NC), miR-200b-3p mimic + si-FOSL2 group (co-transfected with miR-200b-3p mimic and si-FOSL2), miR-200b-3p inhibit + oe-NC group (co-transfected with miR-200b-3p inhibit and oe-NC), miR-200b-3p inhibit + oe-FOSL2 group (co-transfected with miR-200b-3p inhibit and oe-FOSL2). Real-time fluorescence quantitative PCR, Western blot, CCK-8 assay, scratch test and Transwell assay were used to detect the expression of miR-200b-3p mRNA, FOSL2 mRNA and protein, cell proliferation, migration and invasion. In endometrial cancer cell lines, the expression of miR-200b-3p was significantly down-regulated (P < 0.05), while the expression of FOSL2 was significantly up-regulated (P < 0.05). Compared with NC-mimic group, the expression of FOSL2, N-cadherin and Vimentin in miR-200b-3p mimic group was significantly decreased (P < 0.05), and the expression of E-cadherin was significantly increased (P < 0.05). The cell proliferation, migration rate and the number of transmembrane cells were significantly decreased (P < 0.05). Compared with the miR-200b-3p mimic + oe-NC group, the expression of FOSL2, N-cadherin and Vimentin in miR-200b-3p mimic + oe-FOSL2 was significantly increased (P < 0.05), the expression level of E-cadherin was significantly decreased (P < 0.05), and the cell proliferation, migration rate and the number of transmembrane cells were significantly increased (P < 0.05). Compared with NC-inhibit group, the expression of FOSL2, N-cadherin and Vimentin in miR-200b-3p inhibit group was significantly increased (P < 0.05), and the expression of E-cadherin was significantly decreased (P < 0.05). The cell proliferation, migration rate and the number of transmembrane cells were significantly increased (P < 0.05). Compared with the miR-200b-3p inhibit + si-NC group, the expression of FOSL2, N-cadherin and Vimentin in miR-200b-3p inhibit + si-FOSL2 was significantly decreased (P < 0.05), and the expression of E-cadherin was significantly increased (P < 0.05); the cell proliferation, migration rate and the number of transmembrane cells were significantly decreased (P < 0.05) The expression of miR-200b-3p in endometrial cancer cells is down-regulated, which can inhibit the proliferation, migration and invasion of endometrial cancer cells by regulating the EMT process, and its mechanism is related to its targeted negative regulation of FOSL2 expression.
本研究旨在探讨miR-200b-3p如何通过诱导AP1转录家族中FOSL2的表达来抑制子宫内膜癌细胞的增殖和转移。将子宫内膜癌细胞系HEC-1-A分为16组:NC-mimic(转染阴性对照NC mimic)、miR-200b-3p mimic(转染miR-200b-3p mimic)、NC-suppress(转染阴性对照NC抑制物)、miR-200b-3p抑制组(转染miR-200b-3p抑制物)、si-NC(转染阴性对照si-NC)、si-FOSL2(转染Si-FOSL2)、oe-NC(转染阴性对照oe-NC)、oe-FOSL2组(oe-FOSL2)、miR-200b-3p mimic + oe-NC组(共转染miR-200b-3p mimic和oe-NC)、miR-200b-3p mimic + oe-FOSL2组(共转染miR-200b-3p mimic和oe-FOSL2)、miR-200b-3p抑制 + si-NC组(共转染miR-200b-3p抑制物和si-NC)、miR-200b-3p抑制 + si-FOSL2组(共转染miR-200b-3p抑制物和si-FOSL2)、miR-200b-3p mimic + si-NC组(共转染miR-200b-3p mimic和si-NC)、miR-200b-3p mimic + si-FOSL2组(共转染miR-200b-3p mimic和si-FOSL2)、miR-200b-3p抑制 + oe-NC组(共转染miR-200b-3p抑制物和oe-NC)、miR-200b-3p抑制 + oe-FOSL2组(共转染miR-200b-3p抑制物和oe-FOSL2)。采用实时荧光定量PCR、蛋白质免疫印迹法、CCK-8法、划痕试验和Transwell试验检测miR-200b-3p mRNA、FOSL2 mRNA和蛋白表达、细胞增殖、迁移和侵袭情况。在子宫内膜癌细胞系中,miR-200b-3p表达显著下调(P <0.05),而FOSL2表达显著上调(P <0.05)。与NC-mimic组相比,miR-200b-3p mimic组中FOSL2、N-钙黏蛋白和波形蛋白表达显著降低(P <0.05),E-钙黏蛋白表达显著增加(P <0.05)。细胞增殖、迁移率和穿膜细胞数显著降低(P <0.05)。与miR-200b-3p mimic + oe-NC组相比,miR-200b-3p mimic + oe-FOSL2组中FOSL2、N-钙黏蛋白和波形蛋白表达显著增加(P <0.05),E-钙黏蛋白表达水平显著降低(P <0.05),细胞增殖、迁移率和穿膜细胞数显著增加(P <0.05)。与NC-抑制组相比,miR-200b-3p抑制组中FOSL2、N-钙黏蛋白和波形蛋白表达显著增加(P <0.05),E-钙黏蛋白表达显著降低(P <0.05)。细胞增殖、迁移率和穿膜细胞数显著增加(P <0.05)。与miR-200b-3p抑制 + si-NC组相比,miR-200b-3p抑制 + si-FOSL2组中FOSL2、N-钙黏蛋白和波形蛋白表达显著降低(P <0.05),E-钙黏蛋白表达显著增加(P <0.05);细胞增殖、迁移率和穿膜细胞数显著降低(P <0.05)。子宫内膜癌细胞中miR-200b-3p表达下调,可通过调节EMT过程抑制子宫内膜癌细胞的增殖、迁移和侵袭,其机制与其对FOSL2表达的靶向负调控有关。